Epstein M
Nephrology Section, Veterans Administration Medical Center, Miami, FL 33125.
J Cardiovasc Pharmacol. 1991;18 Suppl 9:S21-5.
During the past decade, attention has focused on the effects of calcium antagonists on renal function. When administered in vitro to the isolated perfused kidney, calcium antagonists (including diltiazem) do not affect the vasodilated isolated perfused kidney, but they do dramatically alter the response of this preparation to vasoconstrictor agents. Our recent studies using the isolated perfused hydronephrotic rat kidney model, which permits direct visualization of afferent and efferent arterioles, have demonstrated that the preferential augmentation of glomerular filtration rate induced by calcium antagonists in the isolated perfused kidney is attributable to preferential vasodilation of preglomerular vessels. Although the clinical implications of such observations have not been fully delineated, the results of recent studies indicate that calcium antagonists exert salutary effects on renal function in patients with impaired renal hemodynamics, such as radiocontrast-induced nephrotoxicity and transplant-associated acute renal insufficiency.
在过去十年中,注意力集中在钙拮抗剂对肾功能的影响上。当在体外应用于离体灌注肾脏时,钙拮抗剂(包括地尔硫䓬)不会影响血管舒张的离体灌注肾脏,但它们会显著改变该制剂对血管收缩剂的反应。我们最近使用离体灌注肾积水大鼠肾脏模型的研究,该模型允许直接观察入球小动脉和出球小动脉,结果表明,钙拮抗剂在离体灌注肾脏中诱导的肾小球滤过率的优先增加归因于肾小球前血管的优先舒张。尽管这些观察结果的临床意义尚未完全阐明,但最近的研究结果表明,钙拮抗剂对肾血流动力学受损的患者的肾功能有有益作用,如放射性造影剂诱导的肾毒性和移植相关的急性肾功能不全。